The following article was published by the International Academy of Contemporary Dentistry (iacdentistry.org). It was reprinted with permission from Kate Matsumoto, Executive Director of the iACD. The article highlights Dr. Jon Suzuki (Beta Rho/Illinois Wesleyan 1968).

We would like to congratulate Dr. Jon Suzuki for his appointment to the Food and Drug Administration (FDA) Immunology Devices Panel and Medical Advisory Committee. This prestigious panel is responsible for evaluating the COVID-19 vaccine applications, interpreting the vaccine clinical trial data and ultimately approving the vaccines for use.

Prof. Suzuki is a world-renowned Immunologist. In addition, he is currently the Chairman of the Food and Drug Administration Dental Products Advisory Panel. Most recently, he has been at the forefront for the treatment regimens of peri-implant disease, especially with the use of Nd:YAG lasers (Millenium).

Prof. Suzuki is one of the most published academicians in medicine and dentistry. He has published over 200 research papers, chapters, and symposia, abstracts, and 1 textbook in Medical Technology. Prof. Suzuki also holds Clinical Professorships at the University of Maryland, the University of Washington and Nova Southeastern University.

Prof. Suzuki is Professor Emeritus of Microbiology and Immunology (School of Medicine) and Professor Emeritus of Periodontology and Oral Implantology (School of Dentistry) at Temple University, Philadelphia, PA. USA. He served as Chairman and Director of Graduate Periodontology and Oral Implantology, and Associate Dean for Graduate Education at Temple University. He also served as Dean, Chief of Hospital Dentistry, and CEO of the Faculty Practice Plan at the University of Pittsburgh, USA.